EGFR and cancer: Our previous study has shown that galectin-3 secretion in these cells in such a short-term cell culture condition is minimal.27 In cancers, galectin-3 is typically constantly secreted and could reach higher levels which would impact on EGFR activation by interaction with cancer-associated MUC1.